奧瑞許科技 OSUR 深 滬
等待開盤 09-11 09:30:00 美东时间
3.29
-0.060
-1.79%
華盛通- 最 高3.3858
- 今 開3.36
- 成交量 14.19万股
- 最 低 3.27
- 昨 收 3.35
- 總市值 2.46亿
- 52周最高 4.60
- 市盈率 靜 --
- 換手率 0.19%
- 52周最低 2.36
- 委 比 -70.21%
- 總股本 7480.01万
- 歷史最高 23.01
- 量 比 0.44
- 振 幅 3.46%
- 歷史最低 2.36
- 每 手 1
- 風險率 0.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多OraSure Technologies targeted by investor for proxy battle - report
OraSure Technologies (NASDAQ:OSUR) is being targeted by investor Altai Capital Management, which is preparing to start a proxy fight. The hedge fund recently increased its stake to 5% from 3% at the e...
09-09 20:55
"Healthcare Entrepreneur Ron Zwanziger Threatens 'Adversarial Path' For Orasure Technologies After Company Rebuffs Takeover Bid, Letter Says" - Reuters Exclusive
Orasure stock price has dropped 11% in 4 weeks, 32% in 12 monthsZwanziger offered $3.50-$4 a share, price now under $3/shareOrasure Tech makes COVID-19 rapid-antigen testsLetter says $40 million share repurchase program
08-26 00:03
SM ENERGY PUBLISHES UPDATED SUSTAINABILITY DISCLOSURES
DENVER, Aug. 14, 2025 /PRNewswire/ -- SM Energy Company (the "Company") (NYSE: SM) today announced the publication of its updated sustainability disclosures, all of which are available on th...
08-14 19:30
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
OraSure Appoints Anne Messing as Chief Commercial Officer
OraSure Technologies, Inc. ("OTI") has appointed Anne Messing as its Chief Commercial Officer. With over 25 years of healthcare industry experience, Messing will oversee Sales, Marketing, Strategic Alliances, and Product Management at OTI. She previously led BD Biosciences' U.S. region, driving significant sales growth and successfully launching new products. Messing also held roles at Danaher, Quest Diagnostics, and Siemens Healthcare Diagnostic...
08-04 11:05
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
OraSure Technologies, Inc. has scheduled its earnings conference call for August 5, 2025, at 5 p.m. ET to discuss second quarter 2025 financial results and business developments. A webcast will be available on its investor relations page, and participants can pre-register for the call. The company, which specializes in rapid diagnostic tests and sample collection devices, will also archive the webcast for public access.
07-21 20:05
West Welcomes Robert McMahon as Incoming Chief Financial Officer
EXTON, Pa., July 21, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the appo...
07-21 18:00
Orasure gets takeover bid proposal from Ron Zwanziger- Reuters
Healthcare entrepreneur Ron Zwanziger recently made an unsolicited offer to buy OraSure Technologies, a company known for its COVID-19 rapid tests, according to a report by Reuters. In June, Zwanziger...
07-15 01:58
OSS Announces $2 Million Follow-On Production Order from Innovative Medical Imaging OEM
One Stop Systems (OSS) has secured a $2 million production contract from a medical imaging OEM for non-invasive breast cancer screening. The company expects total program value to reach at least $25 million over five years. OSS will supply 65 next-generation liquid-cooled 3U-SDS systems, marking a transition from pilot to volume production. The 3U-SDS system, designed for edge AI applications, delivers datacenter-class performance in rugged, comp...
07-10 12:00
OraSure Launches Novel Blood Collection Device for Proteomic Research
OraSure Technologies launched HEMAcollect™●PROTEIN, a blood collection tube designed to stabilize plasma proteins in whole blood for up to seven days, addressing limitations of standard tubes. The product, developed by DNA Genotek, enables ambient temperature storage and transport, benefiting proteomic research in oncology, neurology, and other fields. It minimizes hemolysis and platelet activation, supporting various proteomic technologies like ...
07-10 11:05
